Cardiomyopathy and Heart Failure
Clinical research is focused on non-ischemic cardiomyopathy, with particular attention to patients living with heart failure symptoms and changes in left ventricular function.
- Non-ischemic cardiomyopathy
- Left ventricular dysfunction
- Heart failure symptoms
The sponsor’s activity centers on identifying cardiac conditions in which ventricular recovery and symptom control are clinically relevant areas of care.
Cardiac Resynchronization Therapy
Research interest includes patients who have responded strongly to cardiac resynchronization therapy, especially those with marked improvement in cardiac performance after device-based treatment.
- Cardiac resynchronization therapy
- Super-response
- Device-treated cardiomyopathy
This area reflects a focus on the clinical profile of patients whose cardiac function has normalized or substantially improved following resynchronization support.
Neurohormonal Treatment in Cardiac Care
The funded research examines the role of neurohormonal therapy in long-term management of cardiomyopathy, with interest in whether treatment can be withdrawn while maintaining cardiac stability.
- Neurohormonal therapy
- Treatment withdrawal
- Cardiac stability
Clinical interest is directed toward therapy decisions in patients with improved cardiac function and low apparent arrhythmic burden.
Genetic and Structural Cardiac Risk Assessment
Research also involves patients with negative genetic testing and no major structural markers such as late gadolinium enhancement, supporting a narrower clinical profile for study.
- Negative genetic testing
- Late gadolinium enhancement
- Arrhythmia risk assessment
These features point to interest in distinguishing cardiac recovery from underlying disease markers in non-ischemic heart disease.
